Bullish indicating open at $55-$60, IPO prices at $37
Savov Dimitar Slavchev, CEO, CFO, and President of Nika Pharmaceuticals, Inc. (NASDAQ:NIKA), has sold 2 million shares of common stock, according to a recent SEC filing. The sale comes as InvestingPro data shows NIKA’s stock has surged over 220% in the past six months, though the company’s financial health score remains weak at 1.62. The shares were sold at a price of $0.25 each, totaling $500,000. Following this transaction, Slavchev retains ownership of 455,589,500 shares. This activity was reported for the period ending March 18, 2025, and was filed with the SEC on March 19, 2025. With the current stock price at $1 and InvestingPro analysis indicating overvaluation, investors should note the company’s concerning metrics, including a negative return on assets of -1,474% and negative free cash flow. Get deeper insights into insider trading patterns and 12+ additional ProTips with InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.